First AD

Second AD

Jyoti Malhotra, MD, MPH, is the interim division chief of Thoracic Medical Oncology at City of Hope, and an associate professor in the Department of Medical Oncology & Therapeutics and research director of Thoracic Medical Oncology at City of Hope Orange County.

Julia Rotow, MD, and Jyoti Malhotra, MD, MPH, discuss the investigation of sigvotatug vedotin plus pembrolizumab in NSCLC.

Sigvotatug Vedotin Plus Pembrolizumab in NSCLC

OncLive News Network®

® video programs provide lively discussions, insights, and expert perspectives on important issues facing today’s cancer care professionals. One variation of the program, titled, 

, comprises live virtual or on-site premium reporting for oncologists as it covers the latest news and information coming out of the largest annual oncology conferences. 

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Exploring Sigvotatug Vedotin–Based Combinations in Advanced NSCLC